Perspective Therapeutics Inc (NYSEAMERICAN: CATX) stock enjoyed a major increase of 11.2% on 10/8/25. The shares closed at $3.86. Moreover, trading volume in this advance was above average at 137% of normal. The stock has been strong relative to the market over the last nine months and has risen 12.5% during the last week.
Current PriceTarget Research Rating
Perspective Therapeutics has a current Value Trend Rating of A (Highest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing consistent signals. Perspective Therapeutics has a good Power Rating of 71 and a very high Appreciation Score of 85, leading to the Highest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of A. This review will be completed in the next several days.
Be the first to comment